11/23
02:11 am
fbio
Fortress Biotech (NASDAQ:FBIO) was upgraded by analysts at
Wall Street Z
Low
Report
Fortress Biotech (NASDAQ:FBIO) was upgraded by analysts at
Wall Street Z
11/14
09:35 am
fbio
Fortress Biotech GAAP EPS of $0.11, revenue of $17.6M [Seeking Alpha]
Medium
Report
Fortress Biotech GAAP EPS of $0.11, revenue of $17.6M [Seeking Alpha]
11/14
08:41 am
fbio
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Medium
Report
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
11/14
08:30 am
fbio
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
High
Report
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
11/11
05:42 pm
fbio
Fortress Biotech Q3 Earnings Preview [Seeking Alpha]
Low
Report
Fortress Biotech Q3 Earnings Preview [Seeking Alpha]
10/28
10:00 am
fbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
10/23
10:00 am
fbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
10/21
08:30 am
fbio
Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout
Low
Report
Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout
10/18
10:00 am
fbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
10/13
01:50 pm
fbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
10/8
05:58 pm
fbio
Pharma Billionaire Dilip Shanghvi Positions Next Gen For Succession [Forbes]
Medium
Report
Pharma Billionaire Dilip Shanghvi Positions Next Gen For Succession [Forbes]
10/8
05:45 pm
fbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
10/1
03:45 pm
fbio
Fortress Biotech Investigated by the Portnoy Law Firm
Low
Report
Fortress Biotech Investigated by the Portnoy Law Firm
10/1
11:58 am
fbio
INVESTOR ALERT: Investigation of Fortress Biotech, Inc. (FBIO) Announced by Holzer & Holzer, LLC
Low
Report
INVESTOR ALERT: Investigation of Fortress Biotech, Inc. (FBIO) Announced by Holzer & Holzer, LLC
10/1
08:15 am
fbio
Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101 [Yahoo! Finance]
Medium
Report
Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101 [Yahoo! Finance]
10/1
08:05 am
fbio
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing
Low
Report
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing
10/1
08:00 am
fbio
Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101
Medium
Report
Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101
9/28
03:32 am
fbio
Fortress Biotech (NASDAQ:FBIO) was downgraded by analysts at
Wall Street
Low
Report
Fortress Biotech (NASDAQ:FBIO) was downgraded by analysts at
Wall Street